NFKB1 and breast carcinoma: BEX2 has been shown that it activates the NF-kB signaling pathway in breast cancer cells (Naderi et al., 2007), promotes the human glioblastoma cells proliferation via the NF-κB signaling pathway (Meng et al., 2014).